Megakaryocytic expression of miRNA 10a, 17-5p, 20a and 126 in Philadelphia chromosome-negative myeloproliferative neoplasm

Annals of Hematology

Volumn 88, Issue 4, 2009, Pages 325-332

  Hussein, Kais ^a   Dralle, Wiebke ^a   Theophile, Katharina ^a   Kreipe, Hans ^a   Bock, Oliver ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Laser microdissection; Megakaryocytes; Micro RNA; miRNA; Philadelphia chromosome negative chronic myeloproliferative neoplasm

Indexed keywords

JANUS KINASE 2; MICRORNA; MICRORNA 10A; MICRORNA 126; MICRORNA 17 5P; MICRORNA 20A; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXA1; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENETIC CORRELATION; HUMAN; HUMAN CELL; LASER MICRODISSECTION; MAJOR CLINICAL STUDY; MALE; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MUTATIONAL ANALYSIS; MYELOPROLIFERATIVE DISORDER; NUCLEOTIDE SEQUENCE; PHILADELPHIA CHROMOSOME NEGATIVE CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; THROMBOCYTOSIS;

BONE MARROW CELLS; CORE BINDING FACTOR ALPHA 2 SUBUNIT; GENE EXPRESSION; HOMEODOMAIN PROTEINS; HUMANS; LEUKEMIA, MYELOID, CHRONIC, ATYPICAL, BCR-ABL NEGATIVE; MEGAKARYOCYTES; MICRORNAS; MYELOPROLIFERATIVE DISORDERS; TRANSCRIPTION FACTORS;

EID: 60749086311     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-008-0602-9     Document Type: Article

References (24)

1. Lawrie CH (2007) MicroRNAs and haematology: Small molecules, big function. Br J Haematol 137(6):503-512 doi: 10.1111/ j.1365-2141.2007.06611.x
2. Calin GA, Pekarsky Y, Croce CM (2007) The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. Best Pract Res Clin Haematol 20(3):425-437 doi: 10.1016/j.beha.2007.02.003
3. Parker R, Sheth U (2007) P bodies and the control of mRNA translation and degradation. Mol Cell 25(5):635-646 doi: 10.1016/j.molcel.2007.02.011
4. Guglielmelli P, Tozzi L, Pancrazzi A, Bogani C, Antonioli E, Ponziani V, MPD Research Consortium et al (2007) MicroRNA expression profile in granulocytes from primary myelofibrosis patients Exp Hematol.35(11):1708-1718 doi: 10.1016/j.exphem.2007.08.020
5. Bruchova H, Yoon D, Agarwal AM, Mendell J, Prchal JT (2007) Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis. Exp Hematol 35(11):1657-1667 doi: 10.1016/j.exphem.2007.08.021
6. Bruchova H, Merkerova M, Prchal JT (2008) Aberrant expression of microRNA in polycythemia vera. Haematologica 93:1009-1016
7. Venturini L, Battmer K, Castoldi M, Schultheis B, Hochhaus A, Muckenthaler MU et al (2007) Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+cells. Blood 109(10):4399-4405 doi: 10.1182/blood-2006-09-045104
8. James C, Ugo V, Le Couédic JP, Staerk J, Delhommeau F, Lacout C et al (2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434(7037):1144-1148 doi: 10.1038/nature03546
9. Pikman Y, Lee BH, Mercher T, McDowell E, Ebert BL, Gozo M et al (2006) MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Med 3(7):e270 doi: 10.1371/journal.pmed.0030270
10. Tefferi A, Thiele J, Orazi A, Kvasnicka HM, Barbui T, Hanson CA et al (2007) Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: Recommendations from an ad hoc international expert panel. Blood 110(4):1092-1097 doi: 10.1182/ blood-2007-04-083501
11. Garzon R, Pichiorri F, Palumbo T, Iuliano R, Cimmino A, Aqeilan R et al (2006) MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci USA 103(13):5078-5083 doi: 10.1073/pnas.0600587103
12. Eklund EA (2007) The role of HOX genes in malignant myeloid disease. Curr Opin Hematol 14(2):85-89 doi: 10.1097/MOH.0b013e32801684b6
13. Elagib KE, Racke FK, Mogass M, Khetawat R, Delehanty LL, Goldfarb AN (2003) RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation. Blood 101(11):4333-4341 doi: 10.1182/blood-2002-09-2708
14. Langabeer SE, Gale RE, Rollinson SJ, Morgan GJ, Linch DC (2002) Mutations of the AML1 gene in acute myeloid leukemia of FAB types M0 and M7. Genes Chromosomes Cancer 34(1):24-32 doi: 10.1002/gcc.10031
15. Fontana L, Pelosi E, Greco P, Racanicchi S, Testa U, Liuzzi F et al (2007) MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat Cell Biol 9(7):775-787 doi: 10.1038/ncb1613
16. Buhr T, Büsche G, Choritz H, Länger F, Kreipe H (2003) Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens. Am J Clin Pathol 119(1):152-158 doi: 10.1309/PTVGB3DXB8A8M7KD
17. Hussein K, Brakensiek K, Buesche G, Buhr T, Wiese B, Kreipe H et al (2007) Different involvement of the megakaryocytic lineage by the JAK2 V617F mutation in polycythemia vera, essential thrombocythemia and chronic idiopathic myelofibrosis. Ann Hematol 86(4):245-253 doi: 10.1007/ s00277-007-0252-3
18. Bock O, Schlué J, Lehmann U, von Wasielewski R, Länger F, Kreipe H (2002) Megakaryocytes from chronic myeloproliferative disorders show enhanced nuclear bFGF expression. Blood 100(6):2274-2275 doi: 10.1182/blood-2002-06-1811
19. -Delta;ΔCT Method. Methods 25:402-408 doi: 10.1006/meth.2001.1262
20. Hussein K, Bock O, Seegers A, Flasshove M, Henneke F, Buesche G et al (2007) Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation. Blood 109(9):4106-4107 doi: 10.1182/ blood-2006-12-061135
21. Debernardi S, Skoulakis S, Molloy G, Chaplin T, Dixon-McIver A, Young BD (2007) MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia 21(5):912-916
22. Nouzova M, Holtan N, Oshiro MM, Isett RB, Munoz-Rodriguez JL, List AF et al (2004) Epigenomic changes during leukemia cell differentiation: analysis of histone acetylation and cytosine methylation using CpG island microarrays. J Pharmacol Exp Ther 311(3):968-981 doi: 10.1124/ jpet.104.072488
23. Shen WF, Hu YL, Uttarwar L, Passegue E Largman C (2008) MicroRNA-126 regulates hoxa9 by binding to the homeobox. Mol Cell Biol 28:4609-4619
24. Tedeschi FA, Zalazar FE (2006) HOXA9 gene expression in the chronic myeloid leukemia progression. Leuk Res 30(11):1453-1456 doi: 10.1016/ j.leukres.2006.02.022